The herbal preparation STW5 (Iberogast®) has potent and region-specific effects on gastric motility

Neurogastroenterology and Motility

Volumn 16, Issue 6, 2004, Pages 765-773

  Hohenester, B ^a   Ruhl A ^a   Kelber, O ^b   Schemann, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Steigerwald Arzneimittelwerk GmbH   (Germany)

Author keywords

Functional dyspepsia; Gastric motility; Guinea pig; Smooth muscle contractility

Indexed keywords

ATROPINE; CAPSAICIN; N(G) NITROARGININE METHYL ESTER; OMEGA CONOTOXIN GVIA; PLANT EXTRACT; STW 5; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; IBERIS AMARA; MALE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE; STOMACH ANTRUM; STOMACH FUNDUS; STOMACH INNERVATION; STOMACH MOTILITY; STOMACH MUSCLE;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GASTROINTESTINAL MOTILITY; GUINEA PIGS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; ORGAN CULTURE TECHNIQUES; PLANT EXTRACTS; SODIUM CHANNEL BLOCKERS; STOMACH;

EID: 11144288727     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2004.00548.x     Document Type: Article

References (36)

1. Drossman DA, Li Z, Andruzzi E et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
2. Malfertheiner P, Holtmann G, Peitz U et al. Guidelines of the German Society of Digestive and Metabolic Diseases for treatment of dyspepsia. Z Gastroenterol 2001; 39: 937-56.
3. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998; 114: 582-95.
4. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170-81.
5. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002; 97: 2290-9.
6. Talley NJ. Review article: dyspepsia: how to manage and how to treat? Aliment Pharmacol Ther 2002; 16 (Suppl. 4): 95-104.
7. Fisher RS, Parkman HP. Management of nonulcer dyspepsia. N Engl J Med 1998; 339: 1376-81.
8. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2003; CD001960.
9. Moayyedi P. Counting the cost of proton pump inhibitors. Gut 2001; 49: 462-3.
10. Stickel F, Poschl G, Seitz HK, Waldherr R, Hahn EG, Schuppan D. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand J Gastroenterol 2003; 38: 565-8.
11. Madisch A, Melderis H, Mayr G, Sassin I, Hotz J. A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study. Z Gastroenterol 2001; 39: 511-7.
12. Rösch W, Vinson B, Sassin I. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z Gastroenterol 2002; 40: 401-8.
13. Holtmann G, Adam B, Haag S, Collet W, Grunewald E, Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther 2003; 18: 1099-105.
14. Holtmann G, Haag S, Adam B, Funk P, Wieland V, Heydenreich CJ. Effects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia. Phytomedicine 2003; 10 (Suppl. 4): 56-7.
15. Gundermann KJ, Godehardt E, Ulbrich M. Efficacy of a herbal preparation in patients with functional dyspepsia: a meta-analysis of double-blind, randomized, clinical trials. Adv Ther 2003; 20: 43-9.
16. Allescher HD, Bockenhoff A, Knapp G, Wienbeck M, Hartung J. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 2001; 36: 934-41.
17. Saller R, Pfister-Hotz G, Iten F, Melzer J, Reichling J. Iberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome) - from phytomedicine to 'evidence-based phytotherapy.' A systematic review. Forsch Komplementarmed Klass Naturheilkd 2002; 9 (Suppl. 1): 1-20.
18. Khayyal MT, el Ghazaly MA, Kenawy SA et al. Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination. Arzneimittelforschung 2001; 51: 545-53.
19. Reichling J, Saller R. Iberis amara L. (bitter candytuft) - profile of a medicinal plant. Forsch Komplementarmed Klass Naturheilkd 2002; 9 (Suppl. 1): 21-33.
20. Sharkey KA, Williams RG, Dockray GJ. Sensory substance P innervation of the stomach and pancreas. Demonstration of capsaicin-sensitive sensory neurons in the rat by combined immunohistochemistry and retrograde tracing. Gastroenterology 1984; 87: 914-21.
21. Okpanyi SN, Mark M, Wahl M. Gastrointestinal motility modulation with Iberogast. Acta Horticulturae 1993; 332: 227-35.
22. Schempp H, Toth A, Weiser D, Elstner EF. Antioxidative properties of Iberis amara extracts in biochemical model reactions. Arzneimittelforschung 2003; 53: 568-77.
23. Wall FA, Suer AH, Hayter A, Tugwell AC. The effect of ethanol on spontaneous contractions and on the contraction produced by periarterial nerve stimulation and by acetylcholine in the rat isolated ileum. Gen Pharmacol: Vasc Syst 1987; 18: 631-5.
24. Sarna SK. Gastrointestinal longitudinal muscle contractions. Am J Physiol 1993; 265: G156-64.
25. Michel K, Reiche D, Schemann M. Projections and neurochemical coding of motor neurones to the circular and longitudinal muscle of the guinea pig gastric corpus. Pflugers Arch 2000; 440: 393-408.
26. Kong YC, Lee CM, Wong MK, Xu SB. Smooth muscle relaxant effect of dehydroindicolactone. Gen Pharmacol 1986; 17: 593-5.
27. Harmala P, Vuorela H, Tornquist K, Hiltunen R. Choice of solvent in the extraction of Angelica archangelica roots with reference to calcium blocking activity. Planta Med 1992; 58: 176-83.
28. Hohenester B, Rühl A, Schemann, M. Beyond the myths - herbal extracts have potent and region-specific effects on gastric motility (abstract). Gastroenterology 2004; 126: A484.
29. Troncon LE, Bennett RJ, Ahluwalia NK, Thompson DG. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994; 35: 327-32.
30. Troncon LE, Thompson DG, Ahluwalia NK, Barlow J, Heggie L. Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut 1995; 37: 17-22.
31. Stanghellini V, Tosetti C, Barbara G et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-42.
32. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-52.
33. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-68.
34. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45 (Suppl. 2): II37-42.
35. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002; 16: 1641-8.
36. Talley NJ. Review article: functional dyspepsia - should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 107-15.